Liu CC, Ru YX, Li HR, Liu DJ, Liu JY, Zhao SL, Wu. Soluble influenza H3 trimer proteins enhance the breadth and potency of antibody response. Int J Biol Macromol. 2025 Mar 19;307(Pt 4):142240
Seasonal influenza poses a continuing threat to public health. The effectiveness of the influenza vaccine varies across seasons, with protection against H3N2 being notably less reliable. A primary contributor to this variability in vaccine efficacy is the frequent antigenic drift occurring in the major antigenic epitope located within the head domain of H3. In this study, we engineered stable soluble recombinant H3 trimer proteins referred to as HK68-10 and HK14-15, wherein interprotomer disulfide bonds were established to stabilize their trimerization; importantly, native antigenicity was preserved. Our design approach, devoid of conventional trimerization motifs, should be more viable and favorable for vaccine development, as it avoids off-target immune responses and reinforces structural integrity. These two H3 trimer proteins markedly augmented antibody responses towards conserved yet immuno-subdominant epitopes, thereby improving heterologous immuno-protection against H3N2 viruses. Serological experiment results demonstrate that the elicitation of serum cross-reactivity by soluble H3 vaccines depends on stem epitopes and conserved epitopes located within the head region as well. The research findings from this study are of significance for advancing future efforts to improve H3 vaccines.
See Also:
Latest articles in those days:
- The role of T cells in influenza infection and vaccination 11 hours ago
- Pre-Amplified dsDNA-Tag Lateral Flow Assay for Highly Sensitive Point-of-Care Detection of Influenza A H1N1 15 hours ago
- Avian Influenza H5N1 Infection During Pregnancy: Preparing for the Next Flu Pandemic and Improving Perinatal Outcomes 15 hours ago
- Evaluation of the inactivation of avian influenza virus in duck meat through electron beam irradiation 3 days ago
- Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026 3 days ago
[Go Top] [Close Window]


